Gilead's Kite (GILD) and Sangamo Therapeutics (SGMO) Announce Pact to Develop Next-Generation Engineered Cell Therapies For Treatment of Cancer
Kite, a Gilead Company (Nasdaq: GILD) and Sangamo Therapeutics, Inc. (Nasdaq: SGMO) today announced the companies have entered into ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)